(Q56969723)
Statements
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register (English)
K L Hyrich
British Society for Rheumatology Biologics Register
K Watson